Skip to Content

User Reviews for Ribociclib

Also known as: Kisqali

Ribociclib has an average rating of 9.3 out of 10 from a total of 10 ratings on Drugs.com. 100% of users who reviewed this medication reported a positive effect, while 0% reported a negative effect.

Condition Avg. Rating Reviews Compare
Breast Cancer, Metastatic  
9.3
10 reviews 38 medications
Summary of Ribociclib reviews 9.3 10 reviews

Reviews may be moderated to correct grammar/spelling or remove inappropriate language. Reviews that appear to be created by parties with a vested interest in the medication will not be published.

Mumsy · Taken for 2 to 5 years March 16, 2021

Kisqali (ribociclib) for Breast Cancer, Metastatic: “I have been on Kisqali since September 2018, with no disease progression . Tumour markers in the “normal” range. Side effects; nausea, diarrhoea, joint pain, some hair loss in the early stages, the occasional rash or skin sensitivity, fatigue. Having said all of this I am living my life, working full time and travelling when possible ....life is good!”

10 / 10
Was this helpful?YesNo
Anonymous · Taken for less than 1 month February 26, 2021

Kisqali (ribociclib) for Breast Cancer, Metastatic: “With Breast Cancer, Metastasis I am feeling very much better, while using Kisqali. But do have body pains but that can be manageable. Now I can easily run my job and home affairs.”

8 / 10
Was this helpful?YesNo
Quickbread · Taken for 1 to 6 months January 24, 2021

Kisqali (ribociclib) for Breast Cancer, Metastatic: “Metastatic BC tumour showed up behind sternum. I’ve been on medication for almost 2 months. Expected the worst but no negative side effects whatsoever. So far bi monthly blood work and ECG’s give me the green light. WBC count within range. I take 600 mg Kisqali along with 2.5 mg Letrozole. Then hit the mountain and hike for an hour. Feel great. Still work part time. I’m 65. I hope this continues.”

10 / 10
Was this helpful?YesNo
MJ · Taken for 2 to 5 years November 6, 2019

Kisqali (ribociclib) for Breast Cancer, Metastatic: “I started in trial on ribociclib (Kisqali) in July of 2017. Two plus years later I am still stable after seeing a steady decrease in the size of my marker nodes for the first 18 months. Side effects for me have been minimal and my quality if life is excellent!”

9 / 10
Was this helpful?YesNo
Thrifty · Taken for 1 to 6 months May 17, 2019

Kisqali (ribociclib) for Breast Cancer, Metastatic: “On Kisqali for breast cancer mets and after 3 rounds the tumor markers are down and one lesion in left rib has completely cleared up and another in the sternum has shrunk from 4 cm to 2 cm. Lots of side effects but minor compared to IV chemo which I had 15 years ago. Some hair loss, constipation, joint pain, blurry vision on occasion. Still give it 10 out of 10”

10 / 10
Was this helpful?YesNo
pluttifikation · Taken for 1 to 6 months February 7, 2018

Kisqali (ribociclib) for Breast Cancer, Metastatic: “I made it 5 rounds before my liver enzymes just wouldn't go down. It shrunk everything by at least half! My RBC and neutrophils are right on the line. Not sure what's next for me -- I was on the Kisqali/Femara combo with monthly injections of Xgeva and Zoladex. I struggled with constipation and dried out everything -- but that might be from being forced into menopause. If you happen to be on this combo: Some hair thinning, unexplained blurry and double vision, rage!, dementia, balance problems, sleep problems, and thyroid issues -- but from what I've heard, a million times easier than old school chemo. (I have had a brain MRI and it was all clear) Stage 4 de novo, ER+ Her2- Original tumor 8cms with mets to ribs and hip”

8 / 10
Was this helpful?YesNo
DM · Taken for 2 to 5 years November 9, 2020

Kisqali (ribociclib) for Breast Cancer, Metastatic: “De novo diagnosis 3/21/18, started 600mg with 2.5 mg Femara on 3/23/18. Single bone met on right humeral head. Complete remission in July 2019 (after 16 months). 32 months since diagnosis, still clear scans. Some hair thinning at first, along with occasional nausea, blurry vision ( mostly in the am) joint pain and fatigue. Fatigue is the worst part for me, but my quality of life has not changed at all.”

10 / 10
Was this helpful?YesNo
Juneday · Taken for 1 to 6 months May 26, 2018

Kisqali (ribociclib) for Breast Cancer, Metastatic: “I've completed 5 cycles of kisqali with monthly injections of faslodex and zometa. Kisqali has been great with the only side effect being constipation.”

9 / 10
Was this helpful?YesNo
Patti · Taken for 6 months to 1 year September 27, 2020

Kisqali (ribociclib) for Breast Cancer, Metastatic: “Been on Kisqali (ribociclib) since November 2019 and had minimum side effects. Tumour markers continue to drop. Will be having a PET scan soon. Will get back with results.”

10 / 10
Was this helpful?YesNo
Samy · Taken for less than 1 month December 4, 2019

For Breast Cancer, Metastatic: “I have taken ribociclib for less than 10 days and develop a severe infection and very low white cells so I had to stay at hospital for 10 days to clear my infection”

Was this helpful?YesNo

This information is NOT intended to endorse any particular medication. While these reviews might be helpful, they are not a substitute for the expertise, knowledge and judgement of healthcare practitioners.